Clinical Trials in Baltimore

Showing 1121-1140 of 11,213 trials

Physician- and Patient-based Barriers to NGS Testing

NCT07209176

The goal of this study is to improve next-generation sequencing (NGS) testing rates at Johns Hopkins in patients with metastatic prostate cancer. Investigators believe by targeting two barriers, provider-level and patient-level, will improve the testing rate of NGS at Johns Hopkins.

Metastatic Prostate Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins256 participantsStarted Jan 2026

Baltimore, Maryland, United States

COMPLETEDPhase 1< 1 mile

Shigella CVD 31000: Study of Responses With Shigella-ETEC Vaccine Strain CVD 1208S-122

NCT04634513

The purpose of this study is to determine whether a live, oral, combined Shigella-ETEC vaccine candidate, known as strain CVD 1208S-122, is safe and immunogenic.

Shigella InfectionEnterotoxigenic Escherichia Coli Infection

University of Maryland, Baltimore53 participantsStarted Sep 2022

Baltimore, Maryland, United States

Physician- and Patient-based Barriers to NGS Testing

Shigella CVD 31000: Study of Responses With Shigella-ETEC Vaccine Strain CVD 1208S-122

Find Trials by Condition in Baltimore

Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell Lymphoma

PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation

A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer

Burosumab for Fibroblast Growth Factor-23 Mediated Hypophosphatemia in Fibrous Dysplasia

Feasibility of Measuring Volume of Inspiration Via Noninvasive Motion Sensors

The DC Cohort Longitudinal HIV Status Neutral Study

A Weight Loss Study Evaluating Subcutaneous Treatment With AZD9550 and AZD6234 in Combination Against Placebo or Each of the Drugs Alone

Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumors

A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors

Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 50 Years of Age With Non-congenital Myotonic Dystrophy Type 1

A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation

A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.

Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass